Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CuI Catalyzed Radical Cyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108689892B discloses a novel CuI-catalyzed route for 3-sulfonylated indanones, offering mild conditions and high yields for cost-effective pharmaceutical intermediate manufacturing.